المؤلفون: Jean-Pascal Capp, Frédéric Thomas, Antoine M. Dujon, Beata Ujvari, Pascal Pujol, Robert A. Gatenby, Catherine Alix-Panabières, Joel S. Brown

المساهمون: Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), Deakin University, Burwood, Australia, Deakin University [Burwood], Toulouse Biotechnology Institute (TBI), Institut National des Sciences Appliquées - Toulouse (INSA Toulouse), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), H. Lee Moffitt Cancer Center and Research Institute, Unité d'Oncogénétique, CRLCC Val d'Aurelle - Paul Lamarque, University of Tasmania [Hobart, Australia] (UTAS), Université de Montpellier (UM), MAVA foundation, Innovation program under the Marie Sklodowska-Curie grant765492, Fondation ARC pour la Recherche sur le Cancer, Institut National du Cancer (INCA) France, ANR-18-CE35-0009,TRANSCAN,ECOLOGIE ET EVOLUTION DES CANCERS TRANSMISSIBLES(2018), Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)

المصدر: Cancers
Cancers, MDPI, 2021, 13 (15), ⟨10.3390/cancers13153693⟩
Cancers; Volume 13; Issue 15; Pages: 3693
Cancers, 2021, 13 (15), ⟨10.3390/cancers13153693⟩
Cancers, Vol 13, Iss 3693, p 3693 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, [SDV.CAN]Life Sciences [q-bio]/Cancer, Biology, circulating tumor cells, Metastasis, Critical phase, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, Breast cancer, Internal medicine, medicine, metastasis, metastatic process, RC254-282, Metastatic cascade, Drake equation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer, medicine.disease, 3. Good health, 030104 developmental biology, Critical parameter, 030220 oncology & carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8406ca7fccdb5f9798fad19cebc2203aTest
https://hal.inrae.fr/hal-03442172/documentTest

المؤلفون: Eric Assenat, Rosine Guimbaud, Jean-Pierre Daurès, Catherine Alix-Panabières, Benjamin Linot, Marc Ychou, Christelle De La Fouchardiere, Eric Francois, Stéphane Obled, Laure Cayrefourcq, Thibault Mazard, Hélène Senellart, Françoise Perriard, Laurent Mineur, Eric Terrebonne, Marianne Fonck

المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre de Recherches Ecologiques et Evolutives sur le Cancer (MIVEGEC-CREEC), Processus Écologiques et Évolutifs au sein des Communautés (PEEC), Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), Institut Desbrest de santé publique (IDESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Centre Léon Bérard [Lyon], Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Institut Sainte Catherine [Avignon], Institut Bergonié [Bordeaux], Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Cancers
Volume 13
Issue 12
Cancers, Vol 13, Iss 2966, p 2966 (2021)
Cancers, 2021, 13 (12), pp.2966. ⟨10.3390/cancers13122966⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Colorectal cancer, [SDV.CAN]Life Sciences [q-bio]/Cancer, colorectal cancer, circulating tumor cells, Article, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, Internal medicine, medicine, Clinical significance, In patient, CellSearch® system, Prospective cohort study, EPISPOT assay, RC254-282, predictive value, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, medicine.disease, Predictive value, Peripheral blood, Measurable Disease, 030104 developmental biology, 030220 oncology & carcinogenesis, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4597d886d82913534f17af1e694c13f6Test
http://europepmc.org/articles/PMC8231886Test

المؤلفون: Jean-Pascal Capp, Catherine Alix-Panabières, Antoine M. Dujon, Beata Ujvari, Francesco Catania, Aurora M. Nedelcu, Benjamin Roche, Frédéric Thomas

المساهمون: Toulouse Biotechnology Institute (TBI), Institut National des Sciences Appliquées - Toulouse (INSA Toulouse), Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), University of New Brunswick (UNB), Deakin University [Burwood], Centre de Recherches Ecologiques et Evolutives sur le Cancer (MIVEGEC-CREEC), Processus Écologiques et Évolutifs au sein des Communautés (PEEC), Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), Westfälische Wilhelms-Universität Münster = University of Münster (WWU), Deakin University, Burwood, Australia, University Hospital of Montpellier, ANR-18-CE35-0009,TRANSCAN,ECOLOGIE ET EVOLUTION DES CANCERS TRANSMISSIBLES(2018), European Project: 765492, Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), University of Münster

المصدر: Cancers
Cancers, 2021, 13 (9), ⟨10.3390/cancers13092197⟩
Cancers, MDPI, 2021, 13 (9), ⟨10.3390/cancers13092197⟩
Cancers, Vol 13, Iss 2197, p 2197 (2021)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Adaptive value, dormancy, [SDV.CAN]Life Sciences [q-bio]/Cancer, Review, Biology, medicine.disease_cause, Parrondo’s paradox, 03 medical and health sciences, 0302 clinical medicine, medicine, Malignant cells, cancer, metastasis, Parrondo's paradox, Epigenetics, Cancer biology, RC254-282, therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer, medicine.disease, 030104 developmental biology, Oncology, Evolutionary biology, 030220 oncology & carcinogenesis, Spite, Carcinogenesis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b130b313c4c6cc8cc085355676556e6eTest
https://hal.inrae.fr/hal-03274009/file/2021_Capp_Cancers.pdfTest

المؤلفون: Holly A. Swain Ewald, Michael J. Metzger, Susanne Sebens, Irina Kareva, Joel S. Brown, Mathieu Giraudeau, Carlo C. Maley, Jean Pascal Capp, Pascal Pujol, Amy M. Boddy, Benjamin Roche, Robert Noble, Kornelia Polyak, Leonard Nunney, Beata Ujvari, Eric Solary, Frédéric Thomas, Rodrigo Hamede, Antoine M. Dujon, Kateřina Staňková, Andriy Marusyk, Aurora M. Nedelcu, Nicholas McGranahan, Marco Gerlinger, Paul W. Ewald, Robert A. Gatenby, James DeGregori, Sarah R. Amend, Andrew F. Read, Elsa Hansen, Kenneth J. Pienta, Catherine Alix-Panabières, Athena Aktipis

المساهمون: Centre de Recherches Ecologiques et Evolutives sur le Cancer (MIVEGEC-CREEC), Processus Écologiques et Évolutifs au sein des Communautés (PEEC), Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), Deakin University, Burwood, Australia, Deakin University [Burwood], Arizona State University [Tempe] (ASU), Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Johns Hopkins University School of Medicine [Baltimore], University of California [Santa Barbara] (UCSB), University of California, H. Lee Moffitt Cancer Center and Research Institute, Toulouse Biotechnology Institute (TBI), Institut National des Sciences Appliquées - Toulouse (INSA Toulouse), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), University of Colorado [Colorado Springs] (UCCS), University of Louisville, The institute of cancer research [London], Université de La Rochelle (ULR), University of Tasmania [Hobart, Australia] (UTAS), Pennsylvania State University (Penn State), Penn State System, The Francis Crick Institute [London], UCL, Canc Res UK Lung Canc Ctr Excellence, Pacific Northwest Research Institute (PNRI), University of New Brunswick (UNB), Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology [Zürich] (ETH Zürich), Universität Zürich [Zürich] = University of Zurich (UZH), University of California [Riverside] (UCR), Dana-Farber Cancer Institute [Boston], Harvard School of Dental Medicine [Boston] (HSDM), Harvard University [Cambridge], Sorbonne Université (SU), Kiel University, Schleswig-Holstein University Hospitals, Institut Gustave Roussy (IGR), Université Paris-Saclay, Département d'hématologie [Gustave Roussy], Maastricht University [Maastricht], Delft University of Technology (TU Delft), MAVA foundation, French National Research Agency (ANR), Dept. of Advanced Computing Sciences, RS: FSE DACS, RS: FSE DACS Mathematics Centre Maastricht, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), University of California [Santa Barbara] (UC Santa Barbara), University of California (UC), Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), La Rochelle Université (ULR), University of California [Riverside] (UC Riverside), Harvard University

المصدر: Evolutionary applications, vol 14, iss 4
Evolutionary Applications
Evolutionary Applications, Blackwell, 2021, ⟨10.1111/eva.13190⟩
Evolutionary Applications, 14(4), 877-892. Wiley-Blackwell
Evolutionary Applications, 14(4)
Evolutionary Applications, Vol 14, Iss 4, Pp 877-892 (2021)
Evolutionary Applications, 2021, ⟨10.1111/eva.13190⟩
Evolutionary Applications, 14 (4)

مصطلحات موضوعية: 0106 biological sciences, 0301 basic medicine, Evolution, Ecology (disciplines), cancer therapy, contemporary evolution, evolutionary medicine, genetics, neoplasm, species interactions, [SDV.CAN]Life Sciences [q-bio]/Cancer, Biology, 010603 evolutionary biology, 01 natural sciences, Field (computer science), QH301, 03 medical and health sciences, Medicinal and Biomolecular Chemistry, medicine, QH359-425, Genetics, QH426, Ecology, Evolution, Behavior and Systematics, Evolutionary Biology, Cancer prevention, Evolutionary medicine, Cancer, medicine.disease, QR, 3. Good health, 030104 developmental biology, Perspective, Key (cryptography), Portfolio, Engineering ethics, Evolutionary ecology, General Agricultural and Biological Sciences

وصف الملف: application/pdf; text/pdf; application/application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76b31b1c2ff5741c43694f144eb20ca9Test
https://escholarship.org/uc/item/9p20m3jdTest

المؤلفون: Klaus Pantel, Catherine Alix-Panabières

المساهمون: Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Pôle Biologie-Pathologie [CHRU Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)

المصدر: Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology, Nature Publishing Group, 2019, 16 (7), pp.409-424. ⟨10.1038/s41571-019-0187-3⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Neoplasm, Residual, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Cell-Free Nucleic Acids/genetics, Neoplasm Residual/diagnosis, Neoplastic Cells, Circulating/pathology, Precision Medicine, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Neoplasm, In patient, Liquid biopsy, business.industry, Liquid Biopsy, Cancer, Neoplastic Cells, Circulating, Prognosis, Primary lesion, medicine.disease, Precision medicine, Minimal residual disease, 030104 developmental biology, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics, 030220 oncology & carcinogenesis, business, Cell-Free Nucleic Acids

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8152abcae409d0e9098ef6ce5732c30Test
https://doi.org/10.1038/s41571-019-0187-3Test

المؤلفون: Catherine Becht, Nicolas Lozano, Paul van der Leest, Ed Schuuring, Frédérique Duboeuf, Harry J.M. Groen, Pierre-Jean Lamy, Naomi Rifaela, Nicolas Pourel, Catherine Alix-Panabières, Werner Hilgers

المساهمون: Institut médical d'anayse génomique (IMAGENOME), Labosud, University Medical Center Groningen [Groningen] (UMCG), Oncologie Médicale (CCGM), Institut Sainte Catherine [Avignon], University of Groningen [Groningen], Laboratoire Cellules Circulantes Rares Humaines [CHRU Montpellier] (LCCRH), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-CHU Saint-Eloi, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON)

المصدر: Cancers
Cancers, MDPI, 2020, 12 (10), ⟨10.3390/cancers12103002⟩
Cancers, Vol 12, Iss 3002, p 3002 (2020)
Cancers, 12(10):3002, 1-14. MDPI AG
Volume 12
Issue 10

مصطلحات موضوعية: 0301 basic medicine, Oncology, OSIMERTINIB, Cancer Research, medicine.medical_specialty, Concordance, [SDV.CAN]Life Sciences [q-bio]/Cancer, lcsh:RC254-282, Article, 03 medical and health sciences, T790M, 0302 clinical medicine, LUNG-CANCER, TheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY, Internal medicine, tyrosine kinase inhibitors, Medicine, Osimertinib, Liquid biopsy, Lung cancer, MUTATION, non-small cell lung cancer, liquid biopsy, business.industry, OF-AMERICAN-PATHOLOGISTS, circulating DNA, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, 3. Good health, Highly sensitive, 030104 developmental biology, Egfr mutation, 030220 oncology & carcinogenesis, Comparison study, EGFR mutation, business, RESISTANCE

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6143c7d27d4e7f670c72acb95bdb0ba0Test
https://hal.umontpellier.fr/hal-03234785Test

المؤلفون: Luis Enrique Cortés-Hernández, Catherine Alix-Panabières, Zahra Eslami-S

المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM)

المصدر: The Journal of Applied Laboratory Medicine
The Journal of Applied Laboratory Medicine, Oxford University Press, 2020, 5 (5), pp.1027-1037. ⟨10.1093/jalm/jfaa115⟩

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Treatment response, Isolation (health care), Clinical Decision-Making, Medical laboratory, [SDV.CAN]Life Sciences [q-bio]/Cancer, circulating tumor cells, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, Quality of life (healthcare), medicine, Humans, Liquid biopsy, Intensive care medicine, liquid biopsy, business.industry, Value proposition, Cancer, value proposition, General Medicine, health economic, Neoplastic Cells, Circulating, medicine.disease, 3. Good health, 030104 developmental biology, 030220 oncology & carcinogenesis, Quality of Life, Laboratories, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bc795e04ec53390df757f75283d632aTest
https://hal.umontpellier.fr/hal-03342511Test

المؤلفون: Zahra Eslami-S, Hassan Dianat-Moghadam, Maryam Heidarifard, Luis Enrique Cortés-Hernández, Mehdi Azizi, Catherine Alix-Panabières, Mohammad Nouri

المساهمون: Tabriz University of Medical Sciences, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM)

المصدر: Cancers, Vol 12, Iss 867, p 867 (2020)
Cancers
Cancers, MDPI, 2020, 12 (4), pp.867. ⟨10.3390/cancers12040867⟩

مصطلحات موضوعية: 0301 basic medicine, cancer stem cells, Cancer Research, dormancy, therapy resistance, [SDV.CAN]Life Sciences [q-bio]/Cancer, Review, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, Biology, circulating tumor cells, lcsh:RC254-282, Metastasis, Causes of cancer, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, Cancer stem cell, medicine, metastasis, Liquid biopsy, liquid biopsy, immune escape, Cancer, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cancer cell, Cancer research, Cancer dormancy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57fa0f01a30779a73ce4dd8ed0932a21Test
https://www.mdpi.com/2072-6694/12/4/867Test

المؤلفون: Luis Enrique Cortés-Hernández, Catherine Alix-Panabières, Zahra Eslami-S

المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM)

المصدر: Frontiers in Oncology
Frontiers in Oncology, Frontiers, 2020, 10, pp.1055. ⟨10.3389/fonc.2020.01055⟩
Frontiers in Oncology, Vol 10 (2020)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Treatment response, metastatic cascade, [SDV.CAN]Life Sciences [q-bio]/Cancer, circulating-tumor DNA, Review, circulating tumor cells, lcsh:RC254-282, Extracellular vesicles, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, tumor educated platelets, medicine, Liquid biopsy, Metastatic cascade, liquid biopsy, business.industry, Cancer, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Primary tumor, 3. Good health, 030104 developmental biology, Oncology, Circulating tumor DNA, 030220 oncology & carcinogenesis, Cancer research, [SDV.IB]Life Sciences [q-bio]/Bioengineering, extracellular vesicles, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf079ae3abcf924af9924b65954cb564Test
https://pubmed.ncbi.nlm.nih.gov/32850309Test

المؤلفون: Marie-Therese Haider, Laure Cayrefourcq, Nico Hinz, Klaus Pantel, Catherine Alix-Panabières, Daniel J Smit, Manfred Jücker

المساهمون: Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Laboratoire Cellules Circulantes Rares Humaines [CHRU Montpellier] (LCCRH), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-CHU Saint-Eloi

المصدر: Cells
Cells, MDPI, 2020, 9 (9), pp.2129. ⟨10.3390/cells9092129⟩
Volume 9
Issue 9
Cells, Vol 9, Iss 2129, p 2129 (2020)

مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, MESH: Signal Transduction, AKT1, Apoptosis, AKT2, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, Circulating tumor cell, MESH: Protein Kinase Inhibitors, MK2206, Phosphorylation, lcsh:QH301-705.5, MESH: Inhibitory Concentration 50, Chemistry, TOR Serine-Threonine Kinases, drug sensitivity assays, General Medicine, personalized medicine, MESH: Gene Expression Regulation, Neoplastic, Neoplastic Cells, Circulating, targeted therapy, 3. Good health, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, MESH: HEK293 Cells, PI3K/AKT/mTOR pathway, Signal transduction, CTCs, Colorectal Neoplasms, Heterocyclic Compounds, 3-Ring, Signal Transduction, MESH: Cell Line, Tumor, Antineoplastic Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, circulating tumor cells, MESH: Everolimus, MESH: Neoplastic Cells, Circulating, Article, MESH: Cell Adhesion, Inhibitory Concentration 50, 03 medical and health sciences, colorectal carcinoma, Cell Line, Tumor, MESH: Cell Proliferation, Cell Adhesion, Humans, Everolimus, Protein Kinase Inhibitors, Protein kinase B, RAD001, MESH: TOR Serine-Threonine Kinases, Cell Proliferation, MESH: Heterocyclic Compounds, 3-Ring, MESH: Humans, MESH: Phosphorylation, Cell growth, MESH: Proto-Oncogene Proteins c-akt, AKT, dual targeting, MESH: Apoptosis, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, HEK293 Cells, 030104 developmental biology, lcsh:Biology (General), MESH: Phosphatidylinositol 3-Kinases, Cancer research, MESH: Antineoplastic Agents, Proto-Oncogene Proteins c-akt, MESH: Colorectal Neoplasms

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329e37a177f287f26f3e0379a18379f2Test
https://hal.umontpellier.fr/hal-03338498Test